B Hunyady

Summary

Publications

  1. pmc Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study
    Pal Miheller
    2nd Department of Medicine, Semmelweis University, Budapest, Hungary
    BMC Gastroenterol 9:66. 2009
  2. ncbi request reprint Expanded parietal cell pool in transgenic mice unable to synthesize histamine
    B Hunyady
    First Dept of Medicine, Medical Faculty, University of Pecs, Pecs, Hungary
    Scand J Gastroenterol 38:133-40. 2003
  3. doi request reprint [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection]
    Bela Hunyady
    Kaposi Mór Oktató Kórház Belgyógyászati Osztály Kaposvár Pécsi Tudományegyetem, Klinikai Központ I Belgyógyászati Klinika Pécs Ifjúság u 13 7624
    Orv Hetil 152:1997-2009. 2011
  4. ncbi request reprint Susceptibility of dopamine D5 receptor targeted mice to cysteamine
    B Hunyady
    First Department of Internal Medicine, Medical Faculty, University of Pecs, Hungary
    J Physiol Paris 95:147-51. 2001
  5. ncbi request reprint One year follow-up of patients after successful helicobacter pylori eradication therapy
    A Vincze
    First Department of Medicine, Faculty of Medicine, University of Pecs, Pecs, Hungary
    J Physiol Paris 95:457-60. 2001
  6. ncbi request reprint Participation of capsaicin-sensitive afferent nerves in the gastric mucosa of patients with Helicobacter pylori-positive or-negative chronic gastritis
    A Dömötör
    First Department of Medicine, Medical and Health Centre, University of Pecs, H 7643, Pecs, Hungary
    Dig Dis Sci 52:411-7. 2007

Collaborators

  • G Mozsik
  • M Palkovits
  • J Szolcsanyi
  • E Buzas
  • A Falus
  • T Kozicz
  • A Vincze
  • Pal Miheller
  • A Dömötör
  • Zoltan Döbrönte
  • Laszlo Ujszaszy
  • Zsofia Czegledi
  • Gyorgyi Muzes
  • Zsolt Tulassay
  • Janos Papp
  • Peter L Lakatos
  • Maria Papp
  • Tamas Szamosi
  • László Simon
  • Csaba Balázs
  • Tamas Molnar
  • Janos Lonovics
  • Istvan Racz
  • Margit Zeher
  • Karoly Palatka
  • Jozsef Czimmer
  • Zsolt Barta
  • Zsolt Jakab
  • Janos Banai
  • Agnes Salamon
  • Andrea Szabo
  • Gabor Horvath
  • Laszlo Lakatos
  • Ferenc Nagy
  • András Gelley
  • Laszlo Herszenyi
  • György Rumi
  • Istvan Altorjay
  • L Kereskay
  • Gy Szekeres

Detail Information

Publications6

  1. pmc Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study
    Pal Miheller
    2nd Department of Medicine, Semmelweis University, Budapest, Hungary
    BMC Gastroenterol 9:66. 2009
    ..Our objective in this study is to report the nationwide, multicenter experience with IFX induction therapy for CD in Hungary...
  2. ncbi request reprint Expanded parietal cell pool in transgenic mice unable to synthesize histamine
    B Hunyady
    First Dept of Medicine, Medical Faculty, University of Pecs, Pecs, Hungary
    Scand J Gastroenterol 38:133-40. 2003
    ..The histidine decarboxylase enzyme (HDC) is responsible for the synthesis of histamine in mammals. Histidine decarboxylase-deficient (HDC-/-) mice have recently been developed by targeted mutation of the HDC gene...
  3. doi request reprint [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection]
    Bela Hunyady
    Kaposi Mór Oktató Kórház Belgyógyászati Osztály Kaposvár Pécsi Tudományegyetem, Klinikai Központ I Belgyógyászati Klinika Pécs Ifjúság u 13 7624
    Orv Hetil 152:1997-2009. 2011
    ....
  4. ncbi request reprint Susceptibility of dopamine D5 receptor targeted mice to cysteamine
    B Hunyady
    First Department of Internal Medicine, Medical Faculty, University of Pecs, Hungary
    J Physiol Paris 95:147-51. 2001
    ..Out of five different subtypes, mRNA of D5 (=D1b) dopamine receptor is very abundant in the gastric epithelium. D1 receptor selective dopamine agonists have been shown to protect against experimental gastro-duodenal lesions...
  5. ncbi request reprint One year follow-up of patients after successful helicobacter pylori eradication therapy
    A Vincze
    First Department of Medicine, Faculty of Medicine, University of Pecs, Pecs, Hungary
    J Physiol Paris 95:457-60. 2001
    ..The aim of this study was to investigate the Helicobacter pylori (Hp) status of patients who underwent successful eradication therapy 1 year prior to the study and to evaluate their current symptoms...
  6. ncbi request reprint Participation of capsaicin-sensitive afferent nerves in the gastric mucosa of patients with Helicobacter pylori-positive or-negative chronic gastritis
    A Dömötör
    First Department of Medicine, Medical and Health Centre, University of Pecs, H 7643, Pecs, Hungary
    Dig Dis Sci 52:411-7. 2007
    ..pylori-negative versus H. pylori-positive gastritis. In conclusion, CSANs participate in the development of human gastritis, however, their participation does not depend on the presence of Helicobacter pylori as a causative factor...